These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 608943)

  • 1. Myopathies caused by three mutations of the mouse.
    Meier H; MacPike AD
    J Hered; 1977; 68(6):383-5. PubMed ID: 608943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of dy and dy2J, two alleles expressing forms of muscular dystrophy in the mouse.
    Macpike AD; Meier H
    Proc Soc Exp Biol Med; 1976 Apr; 151(4):670-2. PubMed ID: 1265049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histochemical and structural analyses of the phenotypic expression of the dystrophic gene in the 129/ReJ dy/dy and the C57BL/6J dy2J/dy2J mice.
    Butler J; Cosmos E
    Exp Neurol; 1977 Dec; 57(3):666-81. PubMed ID: 923672
    [No Abstract]   [Full Text] [Related]  

  • 4. Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD.
    Moreira Soares Oliveira B; Durbeej M; Holmberg J
    PLoS One; 2017; 12(8):e0181950. PubMed ID: 28771630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene.
    Xu H; Wu XR; Wewer UM; Engvall E
    Nat Genet; 1994 Nov; 8(3):297-302. PubMed ID: 7874173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sarcolemma in the Large(myd) mouse.
    Reed PW; Mathews KD; Mills KA; Bloch RJ
    Muscle Nerve; 2004 Nov; 30(5):585-95. PubMed ID: 15389724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib partially improves laminin α2 chain-deficient muscular dystrophy.
    Körner Z; Fontes-Oliveira CC; Holmberg J; Carmignac V; Durbeej M
    Am J Pathol; 2014 May; 184(5):1518-28. PubMed ID: 24631023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural disease history of the dy2J mouse model of laminin α2 (merosin)-deficient congenital muscular dystrophy.
    Pasteuning-Vuhman S; Putker K; Tanganyika-de Winter CL; Boertje-van der Meulen JW; van Vliet L; Overzier M; Plomp JJ; Aartsma-Rus A; van Putten M
    PLoS One; 2018; 13(5):e0197388. PubMed ID: 29763467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histochemical and autoradiographic study of injured and uninjured dystrophic (C57BL/6J dy2j/dy2j) and normal muscle.
    Dribin LB; Simpson SB
    Exp Neurol; 1977 Sep; 56(3):498-517. PubMed ID: 142019
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultrastructure of muscle spindles in C57BL/6J dy2J/dy2J dystrophic mice.
    James NT; Meek GA
    Experientia; 1979 Jan; 35(1):108-9. PubMed ID: 154410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histochemical and morphological study of dystrophic (C57BL/6J dy2j/dy2j) and normal muscle.
    Dribin LB; Simpson SB
    Exp Neurol; 1977 Sep; 56(3):480-97. PubMed ID: 142018
    [No Abstract]   [Full Text] [Related]  

  • 12. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.
    Straub V; Rafael JA; Chamberlain JS; Campbell KP
    J Cell Biol; 1997 Oct; 139(2):375-85. PubMed ID: 9334342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B.
    Bittner RE; Anderson LV; Burkhardt E; Bashir R; Vafiadaki E; Ivanova S; Raffelsberger T; Maerk I; Höger H; Jung M; Karbasiyan M; Storch M; Lassmann H; Moss JA; Davison K; Harrison R; Bushby KM; Reis A
    Nat Genet; 1999 Oct; 23(2):141-2. PubMed ID: 10508505
    [No Abstract]   [Full Text] [Related]  

  • 14. Bortezomib Does Not Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy.
    Körner Z; Durbeej M
    PLoS One; 2016; 11(1):e0146471. PubMed ID: 26731667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of the dystrophic phenotype after transient neonatal denervation: role of MHC isoforms.
    Ontell MP; Moschella MC; Schiaffino S; Butler-Browne G; Whalen R; Ontell M
    J Neurobiol; 1992 Aug; 23(6):751-65. PubMed ID: 1431844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscular dystrophy in the mouse caused by an allele at the dy-locus.
    Meier H; Southard JL
    Life Sci; 1970 Feb; 9(3):137-44. PubMed ID: 5434356
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased polyamines as protective disease modifiers in congenital muscular dystrophy.
    Kemaladewi DU; Benjamin JS; Hyatt E; Ivakine EA; Cohn RD
    Hum Mol Genet; 2018 Jun; 27(11):1905-1912. PubMed ID: 29566247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X chromosome-linked muscular dystrophy (mdx) in the mouse.
    Bulfield G; Siller WG; Wight PA; Moore KJ
    Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1189-92. PubMed ID: 6583703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing the proliferative capacity of muscular dystrophy myoblasts.
    Yang J; Seelig M; Rayner S; Bredesen DE
    Muscle Nerve; 1992 Aug; 15(8):941-8. PubMed ID: 1495511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Animal models for muscular dystrophy--muscular dystrophy in mice].
    Tsuji S; Matsushita H
    Nihon Rinsho; 1977 Nov; 35(11):3936-42. PubMed ID: 340729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.